This inventor holds 1 USPTO granted patent. Top assignees: Jawaharlal Nehru University, Stellenbosch University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 76 
Years Active: 2026
Title: Arpit Dheeraj: Inventor in Cancer Research
Introduction
Arpit Dheeraj is an inventor associated with New Delhi, India. His work includes a patent concerning modified fisetin compounds and their potential use in cancer treatment. The available information lists 1 patent in his name.
Latest Patents
Dheeraj’s patent, “4′-Substituted Analogues of Fisetin and Their Use in the Treatment of Cancer,” describes compounds based on fisetin, a flavonol. The invention focuses on compounds with a ring-deactivating group at the 4′ position on the B-ring, where the group has a para-Hammett constant greater than zero. The patent describes the potential use of these compounds in treating cancer, including epithelial cancers.
Career Highlights
The information provided associates Dheeraj with Stellenbosch University and Jawaharlal Nehru University. These institutions are part of the academic and research context connected with his career.
Collaborations
The listed collaborators include Catherine Hart Kaschula and Rana Pratap Singh. Their names are associated with Dheeraj’s work on the fisetin analogue invention.
Conclusion
Arpit Dheeraj’s listed patent concerns chemically modified fisetin analogues and their potential application in cancer treatment, reflecting a research focus at the intersection of chemistry and therapeutic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile